DUTCH-WAIST

DUTCH Weight Control in Atrial Fibrillation Study

Stage
inclusie
Medicine
semaglutide
Population
Ritme
Phase
IV
First Patient In
25 July 2024
Last Patient In
31 December 2025
Last Patient Last Visit
31 December 2026

Inclusion period, 32 days remaining

National Lead

dr. M.E.W. Hemels

Cardioloog

Study Director

dr. R. Pisters

Cardioloog

Office Contact

L.C.M. Smit

Projectmanager

The page has expired.